Clinical Trial: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Observational

Official Title:

Brief Summary: Anti-NMDA receptor encephalitis is the most common curable non-infectious autoimmune encephalitis，but because of the lack of recognition in the clinic, usually been misdiagnosed as other causes of encephalitis. Therefore, it is urgent to establish a database of anti-NMDA receptor encephalitis in Chinese population. The multi-center, prospective clinical trial of anti-NMDA receptor encephalitis in China's , combined with Beijing Xuanwu hospital, Beijing Tiantan Hospital, Beijing Children's Hospital and other hospitals around the country, by screening the NMDA receptor antibody and summarizing the cases analysis, in order to provide evidence for clinical diagnosis and treatment of anti-NMDA receptor encephalitis.

Detailed Summary:
Sponsor: Beijing Tongren Hospital

Current Primary Outcome: death [ Time Frame: 30 days ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Beijing Tongren Hospital

Dates:
Date Received: September 23, 2015
Date Started: May 2015
Date Completion:
Last Updated: September 27, 2015
Last Verified: September 2015